These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3186269)

  • 21. [The role of magnetic resonance imaging in the diagnosis of Hallervorden-Spatz disease].
    Tabuchi M; Mori E; Yamadori A
    Rinsho Shinkeigaku; 1990 Sep; 30(9):972-7. PubMed ID: 2265508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myoclonic form of Hallervorden-Spatz disease. Clinical aspect simulating a subacute spongiform encephalitis].
    Radermecker J; Rizzuto N
    Rev Neurol (Paris); 1967 Feb; 116(2):184-8. PubMed ID: 6047744
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonspecific accumulation of metals in the globus pallidus in Hallervorden-Spatz disease.
    Goldberg W; Allen N
    Trans Am Neurol Assoc; 1979; 104():106-8. PubMed ID: 553381
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].
    Carod-Artal FJ; Vargas AP; Marinho PB; Fernandes-Silva TV; Portugal D
    Rev Neurol; 2004 Feb 16-29; 38(4):327-31. PubMed ID: 14997456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.
    Scarano V; Pellecchia MT; Filla A; Barone P
    Mov Disord; 2002 May; 17(3):618-20. PubMed ID: 12112223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography in Hallervorden-Spatz disease.
    Boltshauser E; Lang W; Janzer R; Briner J; Spiess H; Kleihues P; Isler W
    Neuropediatrics; 1987 May; 18(2):81-3. PubMed ID: 3601001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hallervorden-Spatz disease].
    Ohno M; Goto I
    Nihon Rinsho; 1993 Nov; 51(11):2957-61. PubMed ID: 8277577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR imaging in a case of Hallervorden-Spatz disease.
    Tanfani G; Mascalchi M; Dal Pozzo GC; Taverni N; Saia A; Trevisan C
    J Comput Assist Tomogr; 1987; 11(6):1057-8. PubMed ID: 3680689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hallervorden-Spatz disease with bilateral involvement of globus pallidus and substantia nigra: MR demonstration.
    Porter-Grenn L; Silbergleit R; Mehta BA
    J Comput Assist Tomogr; 1993; 17(6):961-3. PubMed ID: 8227584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions.
    Nicholas AP; Earnst KS; Marson DC
    Mov Disord; 2005 Jul; 20(7):880-6. PubMed ID: 15834858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The Hallervorden-Spatz Disease].
    Seitelberger F
    Nervenarzt; 1966 Nov; 37(11):482-93. PubMed ID: 5983175
    [No Abstract]   [Full Text] [Related]  

  • 32. Hallervorden-Spatz syndrome restricted to the pallidal nuclei.
    Kessler C; Schwechheimer K; Reuther R; Born JA
    J Neurol; 1984; 231(3):112-6. PubMed ID: 6481416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.
    Jankovic J; Kirkpatrick JB; Blomquist KA; Langlais PJ; Bird ED
    Neurology; 1985 Feb; 35(2):227-34. PubMed ID: 3969211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR imaging of a group I case of Hallervorden-Spatz disease.
    Mutoh K; Okuno T; Ito M; Nakano S; Mikawa H; Fujisawa I; Asato R
    J Comput Assist Tomogr; 1988; 12(5):851-3. PubMed ID: 3170846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Late Hallervorden-Spatz disease with important reticular and cerebellar participation].
    Evrard E; Hariga J; Martin JJ; Reznik M
    Psychiatr Neurol Neurochir; 1968; 71(3):243-54. PubMed ID: 5687405
    [No Abstract]   [Full Text] [Related]  

  • 36. Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease.
    Balas I; Kovacs N; Hollody K
    Mov Disord; 2006 Jan; 21(1):82-5. PubMed ID: 16108022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical spectrum of Hallervorden-Spatz syndrome in India.
    Sachin S; Goyal V; Singh S; Shukla G; Sharma MC; Gaikwed S; Behari M
    J Clin Neurosci; 2009 Feb; 16(2):253-8. PubMed ID: 19056277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome.
    Tennison MB; Bouldin TW; Whaley RA
    Neurology; 1988 Jan; 38(1):154-5. PubMed ID: 3336450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up MR studies in Hallervorden-Spatz disease.
    Gallucci M; Cardona F; Arachi M; Splendiani A; Bozzao A; Passariello R
    J Comput Assist Tomogr; 1990; 14(1):118-20. PubMed ID: 2298974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.